U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07432633) titled '[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications' on Feb. 10.
Brief Summary: This is a multi-center, open-label, single-arm, Phase 1/2 study designed to evaluate the safety, radiation dosimetry, and preliminary diagnostic performance of [18F]FPyQCP in detecting colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
Study Start Date: Jan. 31
Study Type: INTERVENTIONAL
Condition:
Colorectal Cancer
Epithelial Ovarian Cancer
Gastric Cancer
Invasive Lobular Breast Carcinoma
Pancreatic Duc...